Literature DB >> 7431221

Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.

D Trenk, E Jähnchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7431221     DOI： 10.1007/bf01065192

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  17 in total

1.  [The possibility of colorimetric determination of N-(4-methyl-benzolsulfonyl)-N'-butyl urea in blood].

Authors:  H SPINGLER
Journal:  Klin Wochenschr       Date:  1957-05-15

2.  Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.

Authors:  C M Lai; G Levy
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

Review 3.  Drug protein binding and the nephrotic syndrome.

Authors:  R Gugler; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

4.  Comparative pharmacokinetics of coumarin anticoagulants XXX: Relationship between total clearance and serum protein binding of dicumarol in rats.

Authors:  C M Lai; G Levy
Journal:  J Pharm Sci       Date:  1977-12       Impact factor: 3.534

5.  Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharm Pharmacol       Date:  1977-05       Impact factor: 3.765

6.  Effect of plasma protein binding on the anticoagulant action of warfarin in rats.

Authors:  A Yacobi; G Levy
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-10

7.  Biotransformation of phenprocoumon in the rat.

Authors:  L R Pohl; R E Haddock; W F Trager
Journal:  J Med Chem       Date:  1975-05       Impact factor: 7.446

8.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

9.  Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

10.  Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; U Groth
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953
View more
  8 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.

Authors:  D Trenk; B Winkelmann; E Jähnchen; S Oie
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

3.  Protein binding and drug clearance.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

4.  Protein binding and hepatic clearance: studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  W L Schary; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1983-06

5.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

6.  Influence of obesity on sulfonamide disposition in Zucker rats.

Authors:  S Kaul; W A Ritschel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

Review 7.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 8.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.